LifeMD (LFMD) Return on Capital Employed (2013 - 2025)
LifeMD (LFMD) reported Return on Capital Employed of 20.96% for Q4 2025, up 30297.0% on a YoY basis from N/an in Q4 2024, and up 48.41% quarter-over-quarter from 40.63% in Q3 2025.
LifeMD (LFMD) Return on Capital Employed (2013 - 2025) Analysis & Trends
LifeMD has reported Return on Capital Employed for 13 years, with the latest figure at 20.96% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed rose 30297.0% year-over-year to 20.96%; the trailing twelve-month figure through Dec 2025 stood at 20.96% (up 30297.0% YoY), and the FY2025 full-year result was 24.21%, down 1829492.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 20.96%, up from 40.63% in the prior quarter.
- The five-year high for Return on Capital Employed was 2335.34% in Q4 2022, with the low at 24960.95% in Q3 2021.
- Historically, Return on Capital Employed has averaged 2108.05% across 5 years, with a median of 366.49% in 2024.
- Annual changes were most pronounced in 2021 — Return on Capital Employed plunged 2546029 bps — and 2022, when it soared 2452534 bps.
- LifeMD's Return on Capital Employed stood at 526.59% in 2021, then soared by 543 bps to 2335.34% in 2022, then tumbled by 104 bps to 97.87% in 2023, then sank by 231 bps to 323.93% in 2024, then soared by 94 bps to 20.96% in 2025.
- The last three Return on Capital Employed figures came in at 20.96% (Q4 2025), 40.63% (Q3 2025), and 73.12% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 13.00% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 2.09% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 10.67% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | -163.65% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -4.23% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 21.81% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 4.73% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 4.60% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 2.23% |
| 10 | LifeMD | 226.03 Mn | 226.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.96% |
| Sep 30, 2025 | -40.63% |
| Jun 30, 2025 | -73.12% |
| Mar 31, 2025 | -101.15% |
| Dec 31, 2024 | -323.93% |
| Sep 30, 2024 | -201.83% |
| Jun 30, 2024 | -174.88% |
| Mar 31, 2024 | -116.44% |
| Dec 31, 2023 | -97.87% |
| Sep 30, 2023 | -409.04% |
| Jun 30, 2023 | -801.99% |
| Mar 31, 2023 | -1,207.37% |
| Dec 31, 2022 | 2,335.34% |
| Sep 30, 2022 | -435.61% |
| Jun 30, 2022 | -878.64% |
| Mar 31, 2022 | -455.51% |
| Dec 31, 2021 | -526.59% |
| Sep 30, 2021 | -24,960.95% |
| Jun 30, 2021 | -2,870.29% |
| Mar 31, 2021 | -10,799.53% |